CSIMarket Company Name, Ticker, Competitors, else..


Pfizer Inc  (PFE)
Other Ticker:  
 

Pfizer Inc

PFE's Fundamental analysis



Looking into Pfizer Inc growth rates, revenue grew by 4.31 % in II. Quarter 2024 from the same quarter a year ago. Ranking at No. 829

Major Pharmaceutical Preparations industry recorded growth of revenues by 5.17 %

Pfizer Inc's net profit decreased by -97.95 % in II. Quarter 2024 year on year, to $48 millions.

• More on PFE's Growth


Pfizer Inc
realized a net loss in trailing twelve months.

Pfizer Inc realized cash reduction of $ -0.28 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 2.97.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.77.


• More on PFE's Valuation
 
 Total Debt (Millions $) 69,450
 Dividend TTM ($) 1.65 $
 Dividend Yield TTM (%) 5.76 %
 Revenue/Employee (TTM) $ 632,295
 Net Income/Employee (TTM) $ -29,148
 Receivable Turnover (TTM) 4.99
 Tangible Book Value (Per Share $) -7.32

Pfizer Inc
realized net loss in trailing twelve months.

Pfizer Inc realized cash outflow of $ -0.28per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 2.97.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.77.

Pfizer Inc Price to Book Ratio is at 1.88 lower than Industry Avg. of 85.08. and higher than S&P 500 Avg. of 0

• More on PFE's Valuation

•  Market Capitalization (Millions $) 165,013
•  Shares Outstanding (Millions) 5,696
•  Employees 88,000
•  Revenues (TTM) (Millions $) 55,642
•  Net Income (TTM) (Millions $) -2,565
•  Cash Flow (TTM) (Millions $) -1,575
•  Capital Exp. (TTM) (Millions $) -3,195
•  Total Debt (Millions $) 69,450
•  Dividend TTM ($) 1.65 $
•  Dividend Yield TTM (%) 5.76 %
•  Revenue/Employee (TTM) $ 632,295
•  Net Income/Employee(TTM) $ -29,148
•  Receivable Turnover Ratio (TTM) 4.99
•  Tangible Book Value (Per Share $) -7.32

•  Market Capitalization (Millions $) 165,013
•  Shares Outstanding (Millions) 5,696
•  Employees 88,000
•  Revenues (TTM) (Millions $) 55,642
•  Net Income (TTM) (Millions $) -2,565
•  Cash Flow (TTM) (Millions $) -1,575
•  Capital Exp. (TTM) (Millions $) -3,195


    PFE's Profitability Comparisons
Pfizer Inc faced margin deterioration, primarily through cost pressure. Operating Margin fell in II. Quarter 2024 to 7.6 % from 27.57 % in I. Quarter.

Pfizer Inc net profit margin of 0.36 % is currently ranking no. 43 in Major Pharmaceutical Preparations industry, ranking no. 152 in Healthcare sector and number 2045 in S&P 500.


Profitability by Segment
Total Pharmaceutical 36.84 %
Consumer Healthcare and Vaccines 46.25 %
Total 21.12 %
Animal Health 11.8 %
Other 33.45 %
Diversified 33.45 %
Consumer Healthcare 23.31 %



  Ratio
•   Capital Ratio (MRQ) 0.86
•  Total Debt to Equity (MRQ) 0.79
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 0.25
•  Inventory Turnover Ratio (TTM) 2.2



Pfizer Inc faced margin deterioration, primarily through cost pressure. Operating Margin fell in II. Quarter 2024 to 7.6 % from 27.57 % in I. Quarter.

Pfizer Inc net profit margin of 0.36 % is currently ranking no. 43 in Major Pharmaceutical Preparations industry, ranking no. 152 in Healthcare sector and number 2045 in S&P 500.

• More on PFE's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com